Öztekin ALGÜL, Furkan AYAZ, Ronak Haj ERSAN, Qadar Ahmed ISSE, Rusmeenee KHEEREE

Bisbenzoxazole derivatives had an antiinflammatory effect on in vitro stimulated macrophages

Benzoxazoles are DNA base bioisosteres and studies suggest that their derivatives have antiproliferativeactivities. Based on their antiproliferative activities they have been mostly studied as new generation anticancer drugs.In our study we exploited their antiproliferative effect, aiming to delineate bisbenzoxazole derivatives’ (RHE 231 andRHE 238) potential antiinflammatory effect on mouse macrophages that are activated in vitro through danger signal LPSstimulation. RAW 267.4 mammalian macrophages were activated in the presence of our derivatives with or without dangermimic E. coli derived LPS. We present data that support the strong antiinflammatory activity of the bisbenzoxazolederivatives RHE 231 and RHE 238 on stimulated mammalian macrophages. There was a significant and substantialdecrease in the production levels of TNF-α, IL-1β , and IL-6 proinflammatory cytokines in the presence of RHE 231 andRHE 238. These molecules had an antiproliferative effect on the macrophages and, probably, this was their mechanismof action on the cells to alter their inflammatory functions. Our results show that bisbenzoxazole structures RHE 231and RHE 238 have potential to be used as antiinflammatory drug agents.

PDF

___

1. Arango Duque G, Descoteaux A. Macrophage cytokines: involvement in immunity and infectious diseases. Frontiers in Immunology 2014; 5 (1): 491.
2. Murray RZ, Stow JL. Cytokine secretion in macrophages: SNAREs, Rabs, and membrane trafficking. Frontiers in Immunology 2014; 5 (1): 538.
3. Kawagishi C, Kurosaka K, Watanabe N, Kobayashi Y. Cytokine production by macrophages in association with phagocytosis of etoposide-treated P388 cells in vitro and in vivo. Molecular Cell Research 2001; 1541 (3): 221-230.
4. Cavaillon JM. Cytokines and macrophages. Biomedicine and Pharmacotherapy 1994; 48 (10): 445-453.
5. Scull CM, Hays WD, Fischer TH. Macrophage proinflammatory cytokine secretion is enhanced following interaction with autologous platelets. Journal of Inflammation 2010; 7 (1): 53.
6. Berghaus LJ, Moore JN, Hurley DJ, Vandenplas ML, Fortes BP et al. Innate immune responses of primary murine macrophage-lineage cells and RAW 264.7 cells to ligands of Toll-like receptors 2, 3, and 4. Comparative Immunology, Microbiology and Infectious Diseases 2010; 33 (5): 443-454.
7. Schmitz F, Mages J, Heit A, Lang R, Wagner H. Transcriptional activation induced in macrophages by Toll-like receptor (TLR) ligands: from expression profiling to a model of TLR signaling. European Journal of Immunology 2004; 34 (10): 2863-2873.
8. Soromou LW, Zhang Z, Li R, Chen N, Guo W et al. Regulation of inflammatory cytokines in lipopolysaccharidestimulated RAW 264.7 murine macrophage by 7-O-methyl-naringenin. Molecules 2012; 17 (3): 3574-3585.
9. Gasparini C, Foxwell BM, Feldmann M. RelB/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages. Cytokine 2013; 61 (3): 736-740.
10. Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Critical Reviews in Eukaryotic Gene Expression 2010; 20 (2): 87-103.
11. Lopez-Castejon G, Brough D. Understanding the mechanism of IL-1β secretion. Cytokine and Growth Factor Reviews 2011; 22 (4): 189-195.
12. Manderson AP, Kay JG, Hammond LA, Brown DL, Stow JL. Subcompartments of the macrophage recycling endosome direct the differential secretion of IL-6 and TNFα. Journal of Cell Biology 2007; 178 (1): 57.
13. Grossi G, Di Braccio M, Roma G, Ballabeni V, Tognolini M et al. 1,8-Naphthyridines v. novel N-substituted 5- amino-N,N-diethyl-9-isopropyl [1,2,4]triazolo[4,3-a] [1,8]naphthyridine-6-carboxamides, as potent anti-inflammatory and/or analgesic agents completely devoid of acute gastrolesivity. European Journal of Medicinal Chemistry. 2005; 40 (1): 155-165.
14. Dianzani C, Collino M, Gallicchio M, Di Braccio M, Roma G et al. Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study. Journal of Inflammation 2006; 3 (1): 4.
15. Broide DH. Immunomodulation of allergic disease. Annual Reviews of Medicine 2009; 60 (1): 279-291.
16. Iwalewa EO, McGaw LJ, Naidoo V, Eloff JN. Inflammation: the foundation of diseases and disorders. A review of phytomedicines of South African origin used to treat pain and inflammatory condition. African Journal of Biotechnology 2007; 6 (25): 2868-2885.
17. Ayaz, F. Ruthenium pyridyl thiocyanate complex increased the production of pro-inflammatory TNFα and IL1β cytokines by the LPS stimulated mammalian macrophages in vitro. Molecular Biology Reports 2018; 45 (6): 2307- 2312.
18. Ayaz F, Yuzer A, Ince M. Immunostimulatory effect of zinc phthalocyanine derivatives on macrophages based on the pro-inflammatory TNFα and IL1β cytokine production levels. Toxicology in Vitro 2018; 53(1): 172-177. https://doi.org/10.1016/j.tiv.2018.08.011
19. Hancock REW, Nijnik A, Philpott DJ. Modulating immunity as a therapy for bacterial infections. Nature Reviews Microbiology 2012; 10 (1): 243-254.
20. Kaufmann T, Simon HU. Targeting disease by immunomodulation. Cell Death and Differentiation 2015; 22 (1): 185-186.
21. Julier Z, Park AJ, Briquez PS, Martino MM. Promoting tissue regeneration by modulating the immune system. Acta Biomaterialia 2017; 1 (1): 42.
22. Khalil DN, Smith EL, Brentjens RJ, Wolchok JD. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nature Reviews Clinical Oncology 2016; 13 (5): 273-290.
23. Tan TT, Coussens LM. Humoral immunity, inflammation and cancer. Current Opinion in Immunology 2007; 19 (2): 209-216.
24. Chen DS, Mellman I. Oncology meets immunology: the cancer-immunity cycle. Immunity 2013; 39 (1): 1-10.
25. Guevara-Patiño JA, Turk MJ, Wolchok JD, Houghton AN. Immunity to cancer through immune recognition of altered self: studies with melanoma. Advances in Cancer Research 2003; 90 (1): 157-177.
26. Valdés-Ramos R, Benítez-Arciniega A. Nutrition and immunity in cancer. British Journal of Nutrition 2007; 98 (S1): S127-S132.
27. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010; 140 (6): 883-899.
28. Rakoff-Nahoum S. Why cancer and inflammation Yale Journal of Biology and Medicine 2006; 79 (3-4): 123-130.
29. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420 (6917): 860-867.
30. Algul O, Kaessler A, Apcin Y, Yilmaz A, Jose J. Comparative studies on conventional and microwave synthesis of some benzimidazole, benzothiazole and indole derivatives and testing on inhibition of hyaluronidase. Molecules 2008; 13 (4): 736-748.
31. Ayaz F, Kheeree R, Isse Q, Ersan R, Algul O. DNA base bioisosteres, bis-benzoxazoles, exert anti-proliferative effect on human prostate and breast cancer cells. Journal of the Turkish Chemical Society, Section A: Chemistry 2018; 5 (3): 1145-1152. 10.18596/jotcsa.429504
32. Kaessler A, Algul O, Jose J. A microplate based screening of benzimidazole derivatives on hyaluronidase inhibition at pH 7 and 3.5. Letters of Drug Design and Discovery 2007; 4 (8): 562-569.
33. Algul O, Duran N. Activity of bisbenzimidazole derivatives against Staphylococcus epidermidis. Asian Journal of Chemistry 2007; 19 (4): 3145-3151.
34. Kandeel MM, Abdelall EKA, Abd El Hamid MK, Abdelgawad MA, Philoppes JN. Synthesis and in vitro antitumor activity of new benzothiazole and benzoxazole derivatives. Journal of Chemical and Pharmaceutical Research 2013; 5 (8): 16-21.
35. Shitha G, Amma VK, Kamala B, Babu G, Biju CR. In-silico docking investigation, synthesis and in vitro anticancer study of benzoxazole derivatives. Journal of Drug Delivery Technology 2014; 4 (6): 122-126.
36. Hedidi M, Bentabed-Ababsa G, Derdour A, Roisnel T, Dorcet V et al. Synthesis of C,N’-linked bis-heterocycles using a deprotometalation-iodination-N-arylation sequence and evaluation of their antiproliferative activity in melanoma cells. Bioorganic and Medicinal Chemistry 2014; 22 (13): 3498-3507.
37. Kim D, Won HY, Hwang ES, Kim YK, Choo HP. Synthesis of benzoxazole derivatives as interleukin-6 antagonists. Bioorganic and Medicinal Chemistry 2017; 25 (12): 3127-3134.